$29.78
-1.22-3.94%
Benzinga
Benzinga
Benzinga
화요일, 10월 13
Benzinga
© 2026 Benzinga | All Rights Reserved
Cogent Biosciences (COGT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.56 | $-0.54 | $-0.51 | $-0.52 |
| Actual | $-0.52 | $-0.53 | $-0.61 | $-0.50 |
| Surprise | +7.14% | +1.85% | -19.6% | +3.85% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.55 | $-0.58 | $-0.46 | $-0.38 |
| Revenue | ||||
| Consensus | $666670 | $6.4M | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q2 | Aug 10, 2026 | $-0.52 | $-0.56 | 7.14 % |
| Q1 | May 5, 2026 | $-0.53 | $-0.54 | 1.85 % |
| Q4 | Feb 17, 2026 | $-0.61 | $-0.51 | -19.6 % |
| Q3 | Nov 3, 2025 | $-0.50 | $-0.52 | 3.85 % |